Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Virology|October 1, 2013
Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferretsSeema S Lakdawala, Angela R Shih, Akila Jayaraman, et al.
Plos One|October 4, 2011
Effect of D222G mutation in the hemagglutinin protein on receptor binding, pathogenesis and transmissibility of the 2009 pandemic H1N1 influenza virusJessica A Belser, Akila Jayaraman, Rahul Raman, et al.
Journal of Virology|June 7, 2013
N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A virusesXiangjie Sun, Akila Jayaraman, Pavithra Maniprasad, et al.
Communications Chemistry|November 9, 2023
Enhancing antibody affinity through experimental sampling of non-deleterious CDR mutations predicted by machine learningThomas Clark, Vidya Subramanian, Akila Jayaraman, et al.
Science (New York, N.Y.)|November 11, 2009
Hemagglutinin receptor binding avidity drives influenza A virus antigenic driftScott E Hensley, Suman R Das, Adam L Bailey, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2012
Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferretsMelissa B Pearce, Akila Jayaraman, Claudia Pappas, et al.
Science (New York, N.Y.)|July 4, 2009
Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and miceTaronna R Maines, Akila Jayaraman, Jessica A Belser, et al.
Nature|September 30, 2015
The soft palate is an important site of adaptation for transmissible influenza virusesSeema S Lakdawala, Akila Jayaraman, Rebecca A Halpin, et al.
The Lancet. Infectious Diseases|September 8, 2024
Safety and immunogenicity of mRNA-based seasonal influenza vaccines formulated to include multiple A/H3N2 strains with or without the B/Yamagata strain in US adults aged 50-75 years: a phase 1/2, open-label, randomised trialDenise Hsu, Akila Jayaraman, Alicia Pucci, et al.
Pageof 2